.-S100A11 is a member of the S100 family of EF-hand Ca 2ϩ -binding proteins, which is expressed in smooth muscle and other tissues. Ca 2ϩ binding to S100A11 induces a conformational change that exposes a hydrophobic surface for interaction with target proteins. Affinity chromatography with immobilized S100A11 was used to isolate a 70-kDa protein from smooth muscle that bound to S100A11 in a Ca 2ϩ -dependent manner and was identified by mass spectrometry as annexin A6. Direct Ca 2ϩ -dependent interaction between S100A11 and annexin A6 was confirmed by affinity chromatography of the purified bacterially expressed proteins, by gel overlay of annexin A6 with purified S100A11, by chemical cross-linking, and by coprecipitation of S100A11 with annexin A6 bound to liposomes. The expression of S100A11 and annexin A6 in the same cell type was verified by RT-PCR and immunocytochemistry of isolated vascular smooth muscle cells. The site of binding of S100A11 on annexin A6 was investigated by partial tryptic digestion and deletion mutagenesis. The unique NH2 terminal head region of annexin A6 was not required for S100A11 binding, but binding sites were identified in both NH2-and COOH-terminal halves of the molecule. We hypothesize that an agonist-induced increase in cytosolic free [Ca 2ϩ ] leads to formation of a complex of S100A11 and annexin A6, which forms a physical connection between the plasma membrane and the cytoskeleton, or plays a role in the formation of signaling complexes at the level of the sarcolemma. smooth muscle; protein-protein interaction CA 2ϩ IONS serve as key intracellular messengers that mediate the effects of a variety of extracellular signals (hormones, neurotransmitters, growth factors, shear stress, etc.) in eliciting diverse physiological responses, such as muscle contraction, secretion, metabolism, cell growth and differentiation, and mitogenesis (5). The effects of Ca 2ϩ ions are mediated by a host of Ca 2ϩ -binding proteins that can be divided into three principal classes: EF-hand domain proteins (e.g., calmodulin and S100 proteins), Ca 2ϩ -and phospholipid-binding proteins (e.g., annexins and classic protein kinase C isoenzymes) and Ca 2ϩ storage proteins (e.g., calsequestrin) (5, 22). EF-hand Ca 2ϩ -binding proteins have been classified into 45 subfamilies, including the calmodulin and S100 protein subfamilies (23). S100 proteins, homo-or heterodimers of ϳ22 kDa with two EF hands per monomer, function as Ca 2ϩ sensors that respond to an increase in cytosolic free [Ca 2ϩ 
binding to S100A11 induces a conformational change that exposes a hydrophobic surface for interaction with target proteins. Affinity chromatography with immobilized S100A11 was used to isolate a 70-kDa protein from smooth muscle that bound to S100A11 in a Ca 2ϩ -dependent manner and was identified by mass spectrometry as annexin A6. Direct Ca 2ϩ -dependent interaction between S100A11 and annexin A6 was confirmed by affinity chromatography of the purified bacterially expressed proteins, by gel overlay of annexin A6 with purified S100A11, by chemical cross-linking, and by coprecipitation of S100A11 with annexin A6 bound to liposomes. The expression of S100A11 and annexin A6 in the same cell type was verified by RT-PCR and immunocytochemistry of isolated vascular smooth muscle cells. The site of binding of S100A11 on annexin A6 was investigated by partial tryptic digestion and deletion mutagenesis. The unique NH2 terminal head region of annexin A6 was not required for S100A11 binding, but binding sites were identified in both NH2-and COOH-terminal halves of the molecule. We hypothesize that an agonist-induced increase in cytosolic free [Ca 2ϩ ] leads to formation of a complex of S100A11 and annexin A6, which forms a physical connection between the plasma membrane and the cytoskeleton, or plays a role in the formation of signaling complexes at the level of the sarcolemma. smooth muscle; protein-protein interaction CA 2ϩ IONS serve as key intracellular messengers that mediate the effects of a variety of extracellular signals (hormones, neurotransmitters, growth factors, shear stress, etc.) in eliciting diverse physiological responses, such as muscle contraction, secretion, metabolism, cell growth and differentiation, and mitogenesis (5) . The effects of Ca 2ϩ ions are mediated by a host of Ca 2ϩ -binding proteins that can be divided into three principal classes: EF-hand domain proteins (e.g., calmodulin and S100 proteins), Ca 2ϩ -and phospholipid-binding proteins (e.g., annexins and classic protein kinase C isoenzymes) and Ca 2ϩ storage proteins (e.g., calsequestrin) (5, 22) . EF-hand Ca 2ϩ -binding proteins have been classified into 45 subfamilies, including the calmodulin and S100 protein subfamilies (23) . S100 proteins, homo-or heterodimers of ϳ22 kDa with two EF hands per monomer, function as Ca 2ϩ sensors that respond to an increase in cytosolic free [Ca 2ϩ ] with a conformational change that exposes a hydrophobic site of interaction with a variety of target proteins and thereby regulate their subcellular localization and/or activity (32) . They exhibit unique patterns of tissue-and cell type-specific expression and have been implicated in the Ca 2ϩ -dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control (12) . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via overexpression of the protein (24) . S100A11, originally discovered in this laboratory (10) , is a member of the S100 protein family. It is also known as calgizzarin (38) and S100C (26) . S100A11 exhibits broad tissue distribution, is homodimeric with two Ca 2ϩ -binding sites per 11,282-Da monomer, and exposes a hydrophobic surface on binding Ca 2ϩ (1, 34) . The three-dimensional structure of apo-S100A11 was determined by multidimensional NMR spectroscopy (9) . Comparison with the structure of Ca 2ϩ -saturated S100A11 in complex with a peptide corresponding to the binding site on annexin A1 (annexin I) (30) revealed the conformational change occurring upon Ca 2ϩ binding and confirmed the exposure of a hydrophobic site of interaction with the target peptide. In addition to binding to annexin A1, S100A11 has been shown to interact with actin (42) and transglutaminase (31) , and is capable of forming a heterodimer with S100B through subunit exchange (8) .
The objective of this study was to identify additional molecular targets of S100A11, specifically in smooth muscle.
MATERIALS AND METHODS
Materials. Materials were purchased from the following manufacturers and suppliers: dimethylsuberimidate and SuperSignal West Femto Maximum Sensitivity Substrate (Pierce); dithiothreitol (ICN Biomedicals); soybean trypsin inhibitor (US Biochemical); sequencing grade modified TPCK-trypsin (Promega); DEAE-Sephacel, glutathione-Sepharose 4 Fast Flow, phenyl-Sepharose 6 Fast Flow, protein A-Sepharose CL-4B, HiTrap Protein A and G HP, PreScission protease, vectors pGEX-2TK and pGEX-6P-1 (Amersham Biosciences); Immobilon-P membrane (Millipore); nitrocellulose membrane and Coomassie brilliant blue (Bio-Rad); I-Block (Tropix); goat anti-(rabbit IgG)-horseradish peroxidase conjugate (Chemicon). Other chemicals were purchased from VWR or Sigma-Aldrich and were of analytical grade or better. Molecular weight markers utilized were the Invitrogen BenchMark Protein Ladder, the Fermentas PageRuler Prestained Protein Ladder, the Fermentas PageRuler Prestained Protein Ladder Plus and the Invitrogen 1 kb Plus DNA Ladder. S100A11-Sepharose and annexin A6-Sepharose were prepared from CNBractivated Sepharose 4 Fast Flow beads as described by the manufacturer (Pharmacia Biotech). Coupling efficiency was determined to be Ն80% based on protein concentration measurements before and after coupling. Control columns were prepared in identical fashion but without inclusion of S100A11 or annexin A6. Polyclonal antibodies to full-length chicken gizzard S100A11 were raised in rabbits and the IgG fraction purified as previously described (1) . Polyclonal antibodies to annexin A6 were produced in rabbits by Global Peptide Services (Ft. Collins, CO) by injection of a synthetic peptide corresponding to the 12 NH 2-terminal residues with a COOH-terminal Cys (AKIAQGA-MYRGSC) of rat annexin A6 (NCBI accession no. NP_077070) coupled to keyhole limpet hemocyanin. The IgG fraction was purified from the antiserum by HiTrap Protein A HP chromatography. A monoclonal antibody to rat S100A11 was raised against the purified full-length protein expressed in Escherichia coli and purified by HiTrap Protein G HP chromatography.
Purification of chicken gizzard S100A11. S100A11 was purified from chicken gizzard as previously described (10) and stored at Ϫ80°C.
Affinity chromatography. Frozen chicken gizzards (1 g for smallscale analysis and 25 g for large-scale analysis) were thawed, minced, homogenized with a Polytron (setting 7) for 3 ϫ 10 s in 4 volumes of 30 mM Tris⅐HCl, pH 7.5, 150 mM NaCl, 2 mM EGTA, 1 mM dithiothreitol (DTT), 0.3% (vol/vol) Triton X-100, 0.1 mg/ml leupeptin, 10 g/ml pepstatin A, and centrifuged at 11,400 g for 15 min. The supernatant was diluted 1:1 with 30 mM Tris⅐HCl, pH 7.5, 150 mM NaCl, 2.4 mM CaCl 2, 1 mM DTT, 0.3% Triton X-100, 0.1 mg/ml leupeptin, 10 g/ml pepstatin A to give a final free [Ca 2ϩ ] of 0.2 mM and applied to a column (1 ml for small-scale and 5 ml for large-scale analysis) of S100A11-Sepharose Fast Flow previously equilibrated with 30 mM Tris⅐HCl, pH 7.5, 150 mM NaCl, 0.2 mM CaCl2, and 1 mM DTT (buffer A). Unbound proteins were washed from the column with buffer A and bound proteins eluted with (in mM) 30 Tris⅐HCl, pH 7.5, 150 NaCl, 4 EGTA, and 1 DTT (buffer B). Fractions (0.125 ml for small-scale and 2 ml for large-scale analysis) were collected at a flow rate of 0.5 ml/min for small-scale and 10 ml/h for large-scale analysis.
Purified annexin A6, ⌬(1-20) annexin A6, COOH-terminal halfannexin A6 (M340-D671), and NH2 terminal half-annexin A6 (G5-R339) were dialyzed against buffer A and loaded on the S100A11 affinity column. The column was washed with buffer A until A280 returned to baseline. Bound proteins were eluted with buffer B, and fractions (1 ml) were collected at a flow rate of 10 ml/h and subjected to SDS-PAGE.
Purified chicken S100A11 (0.2 mg) was dialysed against buffer A and applied to an annexin A6-Sepharose Fast Flow affinity column previously equilibrated with buffer A. Unbound protein was washed from the column until A280 returned to baseline. Bound protein was then eluted with buffer B. Fractions (0.5 ml) were collected at a flow rate of 15 ml/h and subjected to SDS-PAGE.
RT-PCR. Total RNAs were prepared from fresh tissues using the RNeasy Mini Kit (Qiagen), and oligo(dT)-primed first-strand cDNAs were prepared from the purified RNAs using either Omniscript (Qiagen) or Sensiscript (Qiagen) reverse transcriptases, according to protocols supplied by the manufacturer. All PCR reactions involved in cloning were performed using high-fidelity ProofStart DNA polymerase (Qiagen). Oligonucleotides were obtained from the University of Calgary Core DNA and Protein Services Facility. All constructs generated in this study were verified by complete sequence analysis at the same facility. Restriction endonucleases and DNA modifying enzymes were from either New England Biolabs or Invitrogen. Vectors used for cloning were dephosphorylated prior to ligation. All clones were first transformed into DH5␣ (Invitrogen) or Top 10 cells (Invitrogen) for purification of plasmid DNAs, which were then transformed into BL21 (DE3) cells (Invitrogen) for isopropyl-␤-Dthiogalactopyranoside (IPTG)-induced expression of recombinant proteins.
Chicken S100A11 cDNA (NCBI accession no. P24479) was amplified and subcloned into pGEX-6P-1 (Amersham Biosciences) via BamHI and SmaI sites, from a first-strand cDNA prepared from chicken gizzard total RNA. The forward primer introduced a BamHI cleavage site (underlined) upstream of the ATG start codon (5Ј-CGGGATCCatgTCCAAGGTT-TCCCCCACT-3Ј) and the reverse primer introduced a SmaI cleavage site (underlined) downstream of the stop codon (5Ј-TCCCCCGGGcta-AGGATGAGGAGGCTGAAC-3Ј).
Rat S100A11 (NCBI accession no. AY688465) was amplified from a rat cerebral vessel first-strand cDNA using oligonucleotides designed against the mouse S100A11 cDNA (NCBI accession no. BC086903) using a KpnI site-containing forward primer (5Ј-GGGGTACCatgCCTA-CAGAGACTGAGAG-3Ј) and a XbaI site-containing reverse primer (5Ј-GCTCTAGAttaGATTCGCTTCTGGGAAGT-3Ј), followed by cloning into the same sites of pcDNA3.0. For protein expression in bacteria, the coding region was amplified using the forward NdeI primer (5Ј-CACACATatgCCTACAGAGACTGAGAGATG-3Ј) and reverse EcoRI primer (5Ј-GTGTGAATTCttaGATACGCTTCTGGGAAG-3Ј) and cloned into the same sites in the expression vector pAED4, a pET-derived expression vector generously provided by Dr. J.-P. Jin (Northwestern University, Chicago, IL).
Chicken annexin A6 (NCBI accession no. Q6B344) was amplified from a first-strand cDNA prepared from chicken gizzard total RNA, and subcloned into pGEX-6P-1 (Amersham Biosciences) via the EcoRI and XhoI sites. The forward primer introduced an EcoRI cleavage site (5Ј-CGGAATTCatgGCACCCAAAGGAAAGGTT-3Ј) and the reverse primer introduced a XhoI cleavage site (5Ј-CCGCTCGAGctaGTCGTC-CCCCCCGCACAG-3Ј). The pGEX-6P-1/(⌬1-20) annexin A6 mutant was prepared by amplifying the above clone using the forward EcoRI site-containing primer (5Ј-CGGAATTCAGCCAGGATGCAGACGC-CTTG-3Ј) and the same reverse primer listed above for the full-length chicken annexin A6. pGEX-6P-1/annexin A6 (G5-R339) was amplified and cloned using the forward EcoRI site-containing primer (5Ј-GAGAGAATTCGGAAAGGTTTACAGGGGCTCGGTGAAGGAC-3Ј) and the reverse XhoI site-containing primer (5Ј-TCTCTCTCGAGtcaCCGATAGGCCACCTGCGCTGCCTCG-3Ј). pGEX-6P-1/annexin A6 (M340-D672) construct was generated from the pGEX-6P-1/annexin A6 clone by digestion with EcoRI and BlpI and replacement of the COOH-terminal fragment released with the annealed oligonucleotides EcoBpuUpper (5Ј-AATTCATGTGGGAGC-3Ј) and EcoBpuLower (5Ј-TAAGCTCCCACATG-3Ј), annealed as described above.
Smooth muscle cells were enzymatically isolated from rat cerebral arteries as previously described (39) and mRNA purified using the RNeasy Mini Kit (Qiagen) with on-column DNase treatment, as described by the manufacturer. Reverse transcription was performed using the Sensiscript RT Kit (Qiagen) with 12 l of isolated RNA as described by the manufacturer. To ensure the presence of RNA and successful transcription of cDNA, a positive control PCR was carried out using primers for RhoA [forward primer: 5Ј-CGGGATCCCGAT-GGCTCCCATC(C/A)GGAAG-3Ј; reverse primer: 5Ј-GGAATTC-CTCACAAGA(T/C)(G/A)AGGCA(A/C)-3Ј] with 4 l of cDNA and recombinant Taq polymerase (Invitrogen) as follows: 94°C for 3 min, 35 cycles of 94°C for 45 s, 55°C for 45 s, and 72°C for 1 min, and extension at 72°C for 10 min. Endothelin-1 and ERG-3 were selected as markers to screen for contamination of the isolated smooth muscle cells with endothelial and neuronal cells, respectively. In each case, nested PCR was performed with 4 l of cDNA, recombinant Taq polymerase and 35 cycles with outer primers (forward primer for endothelin-1: 5Ј-GAGCTGAGAAGGAAGTGCAGAG-3Ј; reverse primer for endothelin-1: 5Ј-GGTCTTGATGCTGTTGCTGATG-3Ј; forward primer for ERG-3: 5Ј-CCCAAGGTTAAAGAGAGGA-CACA-3Ј; reverse primer for ERG-3: 5Ј-AGCGGCACCATATTCT-GAGTATC-3Ј). A 4-l aliquot of this reaction was used as template with nested primers (forward primer for endothelin-1: 5Ј-TGTGTC-TACTTCTGCCACCTG-3Ј; reverse primer for endothelin-1: 5Ј-GC-CTCCAACCTTCTTAGTTTTCTT-3Ј; forward primer for ERG-3: 5Ј-GCAGACGCCACGCATCAAC-3Ј; reverse primer for ERG-3: 5Ј-ACGCACAAGACGCAGGAGAC-3Ј) under the following conditions: 94°C for 3 min, 35 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 30 s, and extension at 72°C for 10 min. To screen for S100A11 and annexin A6 mRNAs, PCR was carried out on 4 l of cDNA using gene-specific primers based on the mouse (NCBI accession no. 086903) and rat (NCBI accession number NM024156) sequences, respectively [forward primer for S100A11: 5Ј-CCTACA-GAGACTGAGCG(G/C/A)TGCAT-3Ј; reverse primer for S100A11: 5Ј-CCTTCTGGTTCTTTGTGAAGGCA-3Ј; forward primer for annexin A6: 5Ј-AGGAGGATTATCACAAGTC-3Ј; reverse primer for annexin A6: 5Ј-ATGTTGAGCAGGTCTATC-3Ј] under the following conditions: 94°C for 3 min, 40 cycles of 94°C for 30 s, 55°C for 30 s and 72°C for 45 s, and extension at 72°C for 10 min for S100A11, and 94°C for 3 min, 40 cycles of 94°C for 45 s, 55°C for 60 s and 72°C for 135 s, and extension at 72°C for 10 min for annexin A6. PCR was carried out on a GeneAmp PCR System 2400 (Perkin Elmer) or MyCycler (Bio-Rad) Thermal Cycler.
Quantitative PCR. mRNA was purified from freshly isolated cerebral arteries pooled from four rats with the RNeasy Mini Kit (Qiagen) with additional on-column digestion of DNA with the RNase-free DNase Set (Qiagen) according to the manufacturer's protocol. Purified RNA was used to synthesize cDNA by reverse transcription using the Sensiscript RT Kit (Qiagen), RNaseOUT ribonuclease inhibitor and oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer (Invitrogen) according to the manufacturer's instructions. Realtime PCR was performed using the QuantiTect SYBR Green PCR kit (Qiagen) according to the manufacturer's instructions in an iCycler Thermal cycler (Bio-Rad) with the following forward and reverse primers, respectively: for ␤-actin, 5Ј-TATGAGGGTTACGCGCTCCC-3Ј and 5Ј-ACGCTCGGTCAGGATCTTCA-3Ј; for calmodulin, 5Ј-GCT-GACCAACTGACTGAAGAG-3Ј and 5Ј-CCCAGAGACCGCAT-CACC-3Ј; for S100A11, 5Ј-GTCCCTGATTGCTGTTTTC-3Ј and 5Ј-GGTCCTTCTGGTTCTTCG-3Ј; for S100A10, 5Ј-TGCTTACATT-TCACAGGTTTGC-3Ј and 5Ј-GTCCACAGCCAGAGGGTC-3Ј; and for annexin A6, 5Ј-GCCGCTTGCCTATTGTGAC-3Ј and 5Ј-GCTGGT-GTATCTGCTCATTGG-3Ј. Reaction efficiencies were Ͼ90% for all primers and were within 5% of each other. Relative quantification was performed by normalizing threshold cycles (C t) values to Ct values of ␤-actin (⌬C t). Results represent the means of triplicate samples from two independent experiments.
Expression and purification of recombinant S100A11. E. coli BL21 (DE3) cells were transformed with the plasmid (pGEX-6P-1/ S100A11) and grown at 37°C until the OD 600 reached 0.6 -0.8. Protein expression was induced by the addition of 0.1 mM IPTG. After 4 h of incubation, the cells were harvested by centrifugation at 8,000 g. The pellet was resuspended in phosphate-buffered saline (PBS; 25 ml) and frozen at Ϫ80°C. The cell pellet was thawed and sonicated (6 ϫ 30 s) on ice. Triton X-100 (1%) was added and mixed gently for 30 min. The solution was centrifuged for 20 min at 15,000 g at 4°C. The supernatant was collected, glutathione-Sepharose 4 Fast Flow beads added and the mixture rotated gently at room temperature for 30 min. Following centrifugation (3,000 g for 1 min at 4°C), the supernatant was discarded and the beads were washed three times with PBS and poured into a column (1.6 ϫ 10 cm). The bound glutathione S-transferase (GST)-S100A11 was eluted with 10 mM reduced glutathione in 50 mM Tris⅐HCl, pH 8.0. The eluate containing GST-S100A11 was collected and dialyzed against (in mM) 50 Tris⅐HCl, pH 7.0, 150 NaCl, 1 EDTA, and 1 DTT. PreScission protease (0.34 U/100 g GST-fusion protein) was added to the dialysate and incubated at 4°C for 16 h. The bulk of the cleaved GST was removed on a glutathione-Sepharose 4 Fast Flow column and further purification of S100A11 was achieved by Ca 2ϩ -dependent hydrophobic interaction chromatography (10).
Expression and purification of full-length and truncated annexin A6 species. Chicken annexin A6 (NCBI accession no. Q6B344) was subcloned into pGEX-6P-1 via the EcoRI and XhoI sites. The forward primer introduced an EcoRI cleavage site (underlined) upstream of the ATG start codon (5Ј-CGGAATTCatgGCACCCAAAGGAAAGGTT-3Ј) and the reverse primer introduced an XhoI cleavage site (underlined) downstream of the stop codon (5Ј-CCGCTCGAGctaGTCGTC-CCCCCCGCACAG-3Ј). The pGEX-6P-1/⌬(1-20) annexin A6, pGEX-6P-1/annexin A6 (G5-R339), and pGEX-6P-1/annexin A6 (M340-D672) constructs were generated from the pGEX-6P-1/annexin A6 construct. E. coli BL21 (DE3) cells were transformed with the different annexin A6 plasmids and grown at 37°C until the OD 600 reached 0.8. Protein expression was induced by the addition of 0.1 mM IPTG. After 3 h of incubation, the cells were harvested by centrifugation at 8,000 g for 10 min. The expressed GST-fusion proteins were purified and the GST moiety removed as described above for recombinant S100A11. The bulk of the cleaved GST was removed on a glutathione-Sepharose 4 Fast Flow column and further purification of annexins was achieved by anion-exchange chromatography. The solution was dialyzed against 20 mM Tris⅐HCl, pH 7.5, and applied to a Mono Q HR 16/10 column previously equilibrated with 20 mM Tris⅐HCl, pH 7.5. The column was washed with 20 mM Tris⅐HCl, pH 7.5, until A 280 returned to baseline and bound proteins were eluted with a linear (0 -0.5 M) NaCl gradient in 20 mM Tris⅐HCl, pH 7.5. Fractions were collected at a flow rate of 0.5 ml/min. In the case of annexin A6 (M340-D672), the protein was eluted from the FPLC column by stepping to 0.18 M NaCl in 20 mM Tris⅐HCl, pH 7.5. All cDNA sequences were verified by the University of Calgary Core DNA and Protein Services Facility. The purity of all recombinant proteins was confirmed by SDS-PAGE.
Cross-linking of S100A11 and annexin A6. Purified recombinant chicken annexin A6 (0.2 mg/ml) was incubated for 10 min at room temperature with purified recombinant chicken S100A11 (0.2 mg/ml) in 0.2 M triethanolamine, pH 8.0, in the presence of 4 mM EGTA or 1 mM CaCl 2. A 50-fold molar excess of dimethylsuberimidate (DMS) relative to annexin A6 was added. Samples were withdrawn 5 h following DMS addition and made 50 mM in Tris to quench the cross-linking reaction. In separate experiments, 5-h incubation with DMS was found to consistently give maximal cross-linking. Controls contained annexin A6 alone or S100A11 alone. Samples containing 10 g of annexin A6 and/or S100A11 were subjected to SDS-PAGE and Western blot analysis with anti-S100A11.
Ca 2ϩ -dependent binding of trypsin-digested annexin A6 to immobilized S100A11. Purified recombinant annexin A6 was dialysed against 25 mM Tris, pH 7.5, diluted to a final concentration of 0.2 mg/ml (10 ml total) and partially digested with 40 g [1:50 (wt/wt) ratio of trypsin:annexin A6] of sequencing grade modified TPCKtrypsin at 30°C for 15 min. Soybean trypsin inhibitor (STI; 1 mg) was added to stop the digestion. Buffer composition was adjusted to 30 mM Tris⅐HCl, pH 7.5, 0.15 M NaCl, 0.2 mM CaCl 2, and 1 mM DTT, and loaded on an S100A11-Sepharose affinity column. The column was washed with 30 mM Tris⅐HCl, pH 7.5, 0.15 M NaCl, 0.2 mM CaCl 2, 1 mM DTT, and 0.1 mg/ml STI until A280 returned to baseline. Bound proteins were eluted with 30 mM Tris⅐HCl, pH 7.5, 0.15 M NaCl, 4 mM EGTA, 1 mM DTT, 0.1 mg/ml STI, and fractions (1 ml) were collected at a flow rate of 10 ml/h.
Gel electrophoresis and Western blot analysis. Protein was extracted from rat caudal arterial smooth muscle strips devoid of endothelium with 0.2 ml of 50 mM Tris⅐HCl, pH 6.8, 1% SDS, 0.1 mM diisopropylfluorophosphate, heated to 95°C for 5 min and mixed at room temperature for 60 min before addition of 0.1 ml of 2ϫ sample buffer and SDS-PAGE at 35 mA for 3.5 h. Proteins were transferred to 0.2-m nitrocellulose membranes for 3 h at 80 V and 4°C in 25 mM Tris, 192 mM glycine, and 20% (vol/vol) methanol. Membranes were blocked with 5% nonfat dried milk or 0.5% (wt/vol) I-Block in Tris-buffered saline (TBS; 20 mM Tris⅐HCl, pH 7.5, 0.5 M NaCl) containing 0.05% Tween (TBST) for 1 h and incubated with primary antibody (polyclonal anti-[rat annexin A6] at 1:10,000 dilution, polyclonal anti-[chicken S100A11] at 1:10,000 dilution or monoclonal anti-[rat S100A11] at 1:100 dilution in TBST containing 1% nonfat dried milk or 0.1% I-Block) for 1 h. Membranes were washed with TBST and incubated with anti-[rabbit IgG]-horseradish peroxidase-conjugated secondary antibody (Chemicon; 1:10,000 dilution) or anti-[mouse IgG]-horseradish peroxidase-conjugated secondary antibody (Chemicon; 1:10,000 dilution) before chemiluminescence detection. SDS-PAGE using 7.5-20% acrylamide gradient gels and Western blot analysis were performed as previously described (40) .
Gel overlay (Far Western analysis). Purified S100A11 (positive control; 1 g) and purified full-length annexin A6, ⌬(1-20) annexin A6, annexin A6 (G5-R339), or annexin A6 (M340-D672) (1 g each) were subjected to SDS-PAGE. The proteins were transferred to 0.2-m nitrocellulose membranes as described above and the membranes dried overnight. Membranes were wet with TBS in the presence of 0.2 mM CaCl 2 or 4 mM EGTA and blocked by treatment with 0.5% (wt/vol) I-Block in TBS for 1 h at room temperature in the presence of 0.2 mM CaCl 2 or 4 mM EGTA. Membranes were incubated with S100A11 (0.1 mg/ml in 30 mM Tris⅐HCl, pH 7.5, 150 mM NaCl, 0. MALDI-TOF, matrix-assisted laser desorption ionization/time-of-flight; MS, mass spectrometry. The 70-kDa S100A11-binding protein (see Fig. 1 ) was cut out of an SDS-polyacrylamide gel, digested with trypsin and peptide masses determined by MALDI-TOF MS. Measured masses are compared with predicted tryptic peptide masses from the sequence of chicken annexin A6 (NCBI accession no. Q6B344). Residue numbers refer to the chicken annexin A6 amino acid sequence (see Fig. 2 ). pH 7.5, 0.15 M NaCl, 1 mM DTT, 1 mM CaCl2, 1 g/ml leupeptin, 1 g/ml pepstatin, 1 mM phenylmethylsulfonyl fluoride (PMSF), rotated end-over-end for 30 min at room temperature and centrifuged at 100,000 g for 30 min. The supernatant was discarded. The pellet was resuspended in 15 volumes of 50 mM Tris⅐HCl, pH 7.5, 0.15 M NaCl, 1 mM DTT, 4 mM EGTA, 1 g/ml leupeptin, 1 g/ml pepstatin, and 1 mM PMSF (buffer C), and homogenized with a Pyrex homogenizer. The homogenate was rotated end-over-end for 15 
Binding of annexin A6 and S100A11 to native liposomes. Binding studies were carried out in a total volume of 0.2 ml of 50 mM imidazole-HCl, pH 7.4, 0.15 M NaCl, 40 l liposomes, 5 g purified recombinant chicken S100A11, and annexin A6 in the presence of 0.2 mM CaCl 2 or 4 mM EGTA at room temperature for 20 min. Samples were centrifuged at 100,000 g for 30 min. The pellets were resuspended in 50 l of 80 mM imidazole, pH 7.4 containing either 4 mM EGTA or 0.2 mM CaCl 2, an equal volume of SDS gel sample buffer was added and boiled for 5 min before SDS-PAGE of supernatant and pellet.
Binding of S100A11 to phosphatidylserine liposomes. Porcine brain phosphatidylserine (4 mg) was dried in a stream of N 2, 50 mM imidazole-HCl, pH 7.4, 0.15 M NaCl (1.5 ml) added, and incubated at 30°C for 30 min. After vortexing, the mixture was sonicated on ice (10 ϫ 30 s). Binding studies were carried out in a total volume of 0.2 ml by incubation for 20 min of purified recombinant chicken S100A11 (0.5-10 g) with liposomes (0.1 mg) in 50 mM imidazoleHCl, pH 7.4, 0.15 M NaCl and either 4 mM EGTA or 0.2 mM CaCl 2. Samples were then centrifuged at 100,000 g for 30 min. Separated supernatants and pellets were boiled in SDS-gel sample buffer for 5 min before SDS-PAGE.
Protein concentration. Protein concentrations were determined using the bicinchoninic acid method (Pierce) or by amino acid analysis at the Alberta Peptide Institute (University of Alberta, Edmonton, AB, Canada).
Mass spectrometry. Matrix-assisted laser desorption ionization/ time-of-flight (MALDI-TOF) mass spectrometry (MS) was carried out in the Southern Alberta Mass Spectrometry Centre at the University of Calgary.
Immunocytochemistry. Rat caudal arterial smooth muscle cells were isolated as follows. Male Sprague-Dawley rats (300 -350 g) were killed by halothane inhalation and decapitation as approved by the Animal Care Committee (Faculty of Medicine, University of Calgary). Excess adventitia and adipose tissue were dissected free from the caudal artery in Ca 2ϩ -free SMDS buffer, freshly prepared daily with ultrapure distilled water, containing (in mM) 120 NaCl, 25 NaHCO 3, 4.2 KCl, 0.6 KH2PO4, 1.2 MgCl2, 11 glucose, and 0.01 CaCl2. Tissue segments were placed over a 0.31-mm needle and moved back and forth 40 times to remove the endothelium and then cut into 1 ϫ 1 mm pieces. Tissues were then incubated in SMDS containing collagenase type 1A (7 mg in 5 ml; Sigma) and Protease type XXVII (0.2 mg in 5 ml; Sigma) for 18 -24 min at 35-37°C with bubbling with 95% O 2-5% CO2. Enzymatic digestion was quenched by gentle washing with cold (4°C) SMDS and placed on ice for 1 h. Single isolated myocytes were obtained by gentle trituration of the digested arteries with a fire-polished Pasteur pipette. Cell suspensions were dropped onto coverslips, left to stand for at least 30 min at room temperature (20°C), fixed with 2% paraformaldehyde in PBS and washed 3 ϫ 5 min with PBS. The cells were permeabilized and Fig. 2 . Amino acid sequence of chicken annexin A6. The amino acid sequence of chicken annexin A6 was deduced from the full-length cloned cDNA sequence, confirmed by sequencing three independent clones and deposited in the NCBI database (accession no. Q6B344). The NH2-terminal head region, which is different in all annexins, is highlighted in yellow and the 8 annexin repeats are highlighted in green. Inverted triangles indicate sensitive sites of tryptic cleavage (see text), one within the NH2-terminal head region and two within the linker region connecting the two halves of the molecule, each of which contains 4 annexin repeat motifs. Putative sites of interaction with S100A11 are underlined.
blocked with quench solution (0.1 M Trizma base, pH 7.4, 1.8% NaCl, 2% BSA, 0.2% Triton X-100). Labeling was performed in a humidified box overnight at 4°C using a 1:1,000 dilution of a polyclonal antibody raised in rabbits against an NH 2-terminal peptide of rat annexin A6 or an undiluted mouse monoclonal antibody directed against full-length rat S100A11. Cells were washed 3 ϫ 5 min with PBS and then treated for 1 h at room temperature with secondary antibody: Alexa 488-conjugated goat anti-rabbit IgG (Invitrogen) or Cy3-conjugated goat anti-mouse IgG (Jackson ImmunoResearch), each diluted 1:2,000 in quench solution. Hoechst 33342 nucleic acid stain (Molecular Probes) was applied at 1:10,000 dilution to visualize the nuclei. Cells were washed 3 ϫ 5 min with PBS before visualization of immunofluorescently labeled cells with a laser-scanning cytometry microscope (model BX50-FLA, CompuCyte) equipped with a cooled scientific charge-coupled device (CCD) camera (Diagnostic Instruments) and CCD detector with Sony XC-003/003P camera.
RESULTS
Affinity chromatography of smooth muscle extract on S100A11-Sepharose. Affinity chromatography was used to identify S100A11 binding proteins in smooth muscle. An extract of chicken gizzard, prepared in the absence of Ca 2ϩ (presence of EGTA) to dissociate S100A11 from its targets, was applied to a column of S100A11-Sepharose in the presence of Ca 2ϩ . Unbound proteins were washed through the column and nonspecifically bound proteins eluted with NaCl. Proteins bound in a Ca 2ϩ -dependent manner were then eluted by chelation of Ca 2ϩ with EGTA. Figure 1 shows a Coomassie blue-stained SDS gel of the EGTA-eluted fractions. Three prominent bands were detected with a relative molecular masses of 70, 44, and 37 kDa. Control experiments (see online supplemental Fig. S1 ) demonstrated that the 70 kDa band did not bind to a control Sepharose column (prepared identically but without S100A11) or if loaded on an S100A11 affinity column in the presence of EGTA. On the other hand, the 44 and 37-kDa proteins bound to both control columns. We conclude that only the 70-kDa protein interacts specifically with S100A11 in a Ca 2ϩ -dependent manner. Fig. 3 . Ca 2ϩ -dependent binding of recombinant annexin A6 to immobilized S100A11 and of recombinant S100A11 to immobilized annexin A6. Coomassie bluestained gels are shown. A: purified recombinant annexin A6 was applied to an S100A11 affinity column in the presence of Ca 2ϩ and bound protein eluted with EGTA. 
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Identification of the S100A11-binding protein as annexin A6.
The 70-kDa band was cut out of the gel, digested with trypsin, and the digest was subjected to MALDI-TOF MS ( Table 1) . The protein was identified as annexin A6 (annexin VI) with an expectation value of 2.3 ϫ 10 Ϫ7 and 24 matched peptides covering 39% of the sequence.
Confirmation of direct Ca 2ϩ
-dependent interaction of S100A11 with annexin A6. Annexin A6 cDNA was cloned from chicken gizzard mRNA by RT-PCR, 5Ј-and 3Ј-rapid amplification of cDNA ends, and sequenced (Fig. 2) . S100A11 and annexin A6 were expressed in E. coli as GST-fusion proteins and the GST moiety removed with PreScission protease. Purified recombinant annexin A6 bound to an S100A11 affinity column in a Ca 2ϩ -dependent manner (Fig. 3A) . In the reciprocal experiment, S100A11 bound to an annexin A6 affinity column in a Ca 2ϩ -dependent manner (Fig. 3B) . S100A11, in the presence of Ca 2ϩ , did not bind to a control column prepared in identical fashion but without annexin A6 (data not shown).
Three additional experimental approaches were used to confirm the Ca 2ϩ -dependent interaction between S100A11 and annexin A6: gel overlay (Far Western analysis), chemical cross-linking and co-precipitation with liposomes.
In gel overlay assays, full-length annexin A6 bound S100A11 in the presence of Ca 2ϩ but not EGTA following SDS-PAGE of annexin A6, transfer to nitrocellulose and overlay with S100A11 (Fig. 4) .
Cross-linking of S100A11 and annexin A6 was observed only in the presence of Ca 2ϩ . , with molecular masses of ϳ81 and 93 kDa, corresponding to complexes of 1 S100A11:1 annexin A6 and 2 S100A11:1 annexin A6. S100A11 in the absence of annexin A6 was cross-linked to dimers and higher-order multimers in a Ca 2ϩ -independent manner (Fig. 5, lanes 1 and 5) . Fig. 4 . Gel overlay analysis of the Ca 2ϩ -dependent interaction between S100A11 and annexin A6. Purified recombinant S100A11, annexin A6 and ⌬(1-20) annexin A6 were subjected to SDS-PAGE and transblotted to nitrocellulose. Blots were incubated with S100A11 in the presence of Ca 2ϩ or EGTA, excess S100A11 was washed out and bound S100A11 was detected with anti-S100A11. Coomassie blue-stained gel (left); gel overlay in the presence of EGTA (middle), and gel overlay in the presence of Ca 2ϩ (right). -dependent cross-linking of S100A11 to annexin A6. S100A11 and annexin A6, alone and together, were incubated with the crosslinking agent DMS as described in MATERIALS AND METHODS. Samples containing 10 g of annexin A6 and/or S100A11 were subjected to SDS-PAGE and Western blotting with anti-S100A11. Lanes 1 and 5, S100A11 cross-linked in the presence of EGTA or Ca 2ϩ , respectively; lanes 2 and 6, annexin A6 cross-linked in the presence of EGTA or Ca 2ϩ , respectively; lanes 3 and 7, untreated S100A11 and annexin A6 in the presence of EGTA or Ca 2ϩ , respectively; lanes 4 and 8, S100A11 and annexin A6 crosslinked in the presence of EGTA or Ca 2ϩ , respectively. Results are representative of 3 independent experiments.
Liposomes are known to bind annexin A6 in a Ca 2ϩ -dependent manner (19) . We reasoned, therefore, that it should be possible to confirm the Ca 2ϩ -dependent binding of S100A11 to annexin A6 in the presence of Ca 2ϩ using a coprecipitation assay. Liposomes isolated from rat caudal arterial smooth muscle were incubated with S100A11 and/or annexin A6 in the absence or presence of Ca 2ϩ and centrifuged at a high speed to pellet the liposomes and bound proteins. Separated pellets and supernatants were analyzed by SDS-PAGE and Coomassie blue staining (Fig. 6) . These results confirmed that annexin A6 bound to liposomes in the presence but not absence of Ca 2ϩ (lanes 8 and 9) : all the annexin A6 was recovered in the pellet fraction in the presence of Ca 2ϩ and in the supernatant in the presence of EGTA. Surprisingly, however, S100A11 also bound to liposomes in a Ca 2ϩ -dependent manner (lanes 11 and 12) : in the absence of Ca 2ϩ , all the S100A11 was recovered in the supernatant, but in the presence of Ca 2ϩ some was recovered in the pellet fraction. Nevertheless, more S100A11 bound to liposomes in the presence than in the absence of annexin A6 (compare lanes 15 and 12) . This was confirmed by quantification by scanning densitometry of the amount of S100A11 in the pellet and supernatant in the absence and presence of annexin A6: after subtracting the amount of S100A11 bound to liposomes in the absence of annexin A6, 0.38 Ϯ 0.07 g (n ϭ 4) of S100A11 bound to 2.5 g of liposome-bound annexin A6. This corresponds to 1:1 molar stoichiometry or 1 S100A11 dimer:2 annexin A6 monomers.
The ability of S100A11 to interact with phospholipid in a Ca 2ϩ -dependent manner was confirmed by coprecipitation with liposomes prepared from phosphatidylserine. Different amounts of S100A11 were incubated with phosphatidylserine liposomes in the absence and presence of Ca 
Identification of S100A11-binding domains in annexin A6.
The NH 2 -terminal head regions of annexin A1 and annexin A2 mediate their binding to S100A11 and S100A10, respectively (29, 30) . To determine whether the unique NH 2 -terminal head region of annexin A6 is involved in binding to S100A11, a deletion mutant lacking this domain [⌬ (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) annexin A6] was expressed and purified. Figure 7 shows that this deletion mutant of annexin A6 binds to immobilized S100A11 in a Ca 2ϩ -dependent manner. The NH 2 -terminal head region of annexin A6 is, therefore, not required for interaction with S100A11. The Ca 2ϩ -dependent interaction of S100A11 with annexin A6 lacking the NH 2 terminal head region was confirmed in gel overlay assays (Fig. 4) .
To gain further insight into the binding site(s) on annexin A6 for S100A11, annexin A6 was partially digested with trypsin. SDS-PAGE analysis of the partial tryptic digest indicated prominent fragments of ϳ68 and ϳ34 kDa, suggesting that cleavage occurred near one end of the molecule to generate the 68-kDa fragment and near the middle of the molecule to generate two halves of ϳ34 kDa each (Fig. 8, lane 4) . The digest was subjected to affinity chromatography on immobilized S100A11 and all fragments bound in a Ca 2ϩ -dependent manner (Fig. 8, lanes 13-18) . The 34-kDa bands were cut out of the gel, completely digested with trypsin and subjected to MALDI-TOF MS. Several annexin A6 peptides were detected, which were evenly distributed throughout the length of the molecule, although no peptides at the extreme NH 2 -or COOHtermini were detected ( Table 2 ). The 68-and 34-kDa tryptic fragments of annexin A6 were transblotted from separate gels to polyvinylidenedifluoride (PVDF) membrane and their NH 2 -terminal sequences determined by Edman degradation (Table   3 ). MALDI-TOF MS analysis of the tryptic digest generated four principal peaks (Fig. 9A) , one of which (19, 984 .72 Da) is attributable to the soybean trypsin inhibitor used to terminate the trypsin digestion. Table 4 summarizes these MS data, which support the results of Edman degradation and provide additional information about the COOH-terminal ends of the peptide fragments. Thus the 68-kDa fragment corresponds to G5-D672, and the 34-kDa fragments include M340-D672 and V349-D672. An additional peak is evident (Fig. 9B ) of 37,883 Da, corresponding to G5-R339 (Table 4) . Full-length annexin A6 gave a molecular mass by MS of 76,087.18 Da (Fig. 9C) , which contains a short NH 2 -terminal extension due to the cleavage by PreScission protease (Table 4) . From the data of Figs. 8 and 9 and Tables 2-4, we conclude that annexin A6 is cleaved by trypsin at Lys4 within the NH 2 -terminal head region and at Arg339 and Lys348 in the linker region connecting the two halves of the molecule (each containing 4 annexin repeats). All of these tryptic fragments bound to immobilized S100A11 in a Ca 2ϩ -dependent manner (Fig. 8) , indicating that annexin A6 contains binding sites for S100A11 in each half of the molecule. The 34-kDa tryptic peptides of annexin A6 (Fig. 8) were cut out of an SDS-polyacrylamide gel, digested with trypsin, and peptide masses determined by MALDI-TOF MS. Measured masses are compared with predicted tryptic peptide masses from the sequence of chicken annexin A6. Residue numbers refer to the chicken annexin A6 amino acid sequence (Fig. 2) .
Fragments corresponding to the NH 2 -(G5-R339) and COOH-terminal (M340-D672) halves of annexin A6 were expressed in E. coli and purified following cleavage by PreScission protease. Ca 2ϩ -dependent binding of each half-molecule to S100A11 was confirmed by affinity chromatography (see online supplementary Fig. S3 ) and gel overlay (see online supplementary Fig. S4) .
Coexpression of S100A11 and annexin A6 in smooth muscle tissue and in isolated smooth muscle cells. Western blot analysis has revealed the expression of S100A11 and annexin A6 in smooth muscle tissues (1, 29) . We confirmed this conclusion by Western blot analysis of rat caudal arterial smooth muscle (see online supplementary Fig. S5 ). However, smooth muscle tissues contain many different cell types, including endothelial cells, neurons, and fibroblasts, in addition to smooth muscle cells, and, if the S100A11-annexin A6 interaction is of physiological relevance, the two proteins must be coexpressed in the same cell. RT-PCR was therefore performed on mRNA prepared from isolated vascular smooth muscle cells of the rat basilar artery and indicated that both S100A11 and annexin A6 messages are indeed expressed in smooth muscle cells: PCR products of the expected sizes (148 and 478 bp, respectively) were detected (Fig. 10) . Real-time PCR on mRNA isolated from rat cerebral arteries allowed the quantification of message levels in the tissue relative to the ␤-actin housekeeping gene (Table 5 ). S100A11 mRNA was found to be 20% and annexin A6 mRNA 8% of the ␤-actin content. For comparison, the levels of two other EF-hand Ca 2ϩ -binding proteins, calmodulin and S100A10, were similar to the S100A11 message level (19% and 17%, respectively of the ␤-actin content). Dual-labeling immunocytochemistry confirmed at the protein level that both annexin A6 and S100A11 are expressed in isolated vascular smooth muscle cells (Fig. 11 , left and middle panels, respectively). The nucleus, identified by Hoechst nucleic acid stain (Fig. 11, right panel) , was not stained with either antibody. The specificity of antibody staining was confirmed by loss of the immunofluorescent signal following preadsorption of the primary antibodies with the annexin A6 peptide to which the antibody to annexin A6 was raised (Fig. 11) or full-length S100A11 (Fig. 11, bottom left) , respectively, and the absence of an immunofluorescence signal following treatment with secondary antibody alone (Fig. 11, bottom right) .
DISCUSSION
Annexins bind negatively charged phospholipids and membranes in a Ca 2ϩ -dependent and reversible manner (2, 18) . They contain a highly conserved structural element, the an- Fig. 9 . Mass spectrometric analysis of the tryptic digest of annexin A6. A: tryptic digest of annexin A6 corresponding to the sample in lane 4 of Fig. 8 was subjected to matrix-assisted laser desorption ionization (MALDI)/time-offlight (TOF) mass spectrometry (MS) analysis. The 19,985 Da peak corresponds to soybean trypsin inhibitor used to terminate the digestion by trypsin. A cluster of peaks is observed corresponding to the protein bands of ϳ34 kDa detected on SDS-PAGE, and the peak at 74,839 Da corresponds to the 68 kDa band (Fig. 8) . The results are detailed in Table 4 . B: expansion of the region of the spectrum around 34 kDa to show three distinct peaks at 35,991, 37,027, and 37,883 Da. C: MALDI-TOF MS analysis of intact, bacterially expressed chicken annexin A6. The 68 and 34 kDa tryptic fragments of annexin A6 (Fig. 8) were separated by SDS-PAGE, transblotted to PVDF membrane and their NH2-terminal sequences determined by Edman degradation. Since the 34 kDa band appeared to contain more than one peptide (see Table 4 ), this band was cut into upper and lower components. The lower component contained 3 peptides which differed in NH2-terminal sequence. Residue numbers refer to the chicken annexin A6 amino acid sequence (Fig. 2). nexin repeat, which consists of ϳ70 amino acids. Most annexins contain four such repeat motifs packed into a highly ␣-helical disk, which forms the membrane-binding module. Annexins differ primarily in the NH 2 -terminal head region, which varies in length. For example, annexin A1 has an NH 2 -terminal head region composed of 40 amino acids, the first 10 -14 residues of which constitute the S100A11-binding site (30) . Other S100-annexin partnerships have also been identified. Annexin A2 forms a tetramer composed of two subunits of annexin A2 and two of S100A10, which is Ca 2ϩ -independent (20) . Annexins A2, A6, and A11 interact with S100A6 (calcyclin) in a Ca 2ϩ -dependent manner (16, 36, 41) . S100B binds to annexins A2 (6), A5, and A6 (17) . Finally, S100A1 interacts with annexins A5 and A6 (17) .
Annexins have been implicated in diverse physiological functions, including regulation of membrane organization, membrane trafficking, membrane-cytoskeleton linkage, ion conductance across membranes, anti-inflammatory and anticoagulant effects, and as mediators or regulators of certain cell-cell and cell-matrix interactions (18) . Annexin A6 specifically has been implicated in modulation of Ca 2ϩ and K ϩ conductance (25), Ca 2ϩ homeostasis (21) and cell growth and proliferation (37, 15) . The formation of tetramers composed of two annexin subunits and two S100 subunits could link two distinct membranes in a Ca 2ϩ -dependent manner. Annexins have also been shown to bind to actin-based cytoskeletal elements (e.g., 11, 20, 28), which could explain their possible involvement in Ca 2ϩ -dependent regulation of membrane-cytoskeleton dynamics.
As noted above, S100A11 is known to bind to annexin A1 in a Ca 2ϩ -dependent manner. However, we did not observe annexin A1 in the EGTA eluate following affinity chromatography of an extract of chicken gizzard smooth muscle on immobilized S100A11. This could be due to lack of expression of annexin A1 in this tissue, or levels of expression that are below the limit of detection by Coomassie blue staining following SDS-PAGE of column fractions. We did, however, identify a novel S100-annexin partnership between S100A11 and annexin A6. The direct Ca 2ϩ -dependent interaction of S100A11 with annexin A6 was confirmed by affinity chromatography with purified recombinant proteins (binding of annexin A6 to S100A11-Sepharose and of S100A11 to annexin A6-Sepharose), gel overlay, chemical cross-linking and co-precipitation with liposomes. Deletion mutagenesis indicated that the small NH 2 -terminal head region of annexin A6 is not required for S100A11 binding. This is perhaps not surprising since the NH 2 -terminal head region of annexin A6 is small compared with other annexins known to interact with S100 proteins, e.g., annexins A1 and A2, and it lacks the consensus S100-binding motif, ⌽X⌽⌽XX⌽ (where ⌽ denotes a hydrophobic amino acid and X is any amino acid). On the other hand, examination of the amino acid sequence of annexin A6 reveals three putative S100-binding consensus sequences: V157-A163, L241-V247, and V590-V596 (Fig. 2) . Consistent with this prediction, we have shown that there are distinct S100A11-binding sites within each half of the annexin A6 molecule, as shown by the S100A11-binding properties of tryptic fragments and deletion mutants of annexin A6. Thus, tryptic fragments corresponding to G5-R339, M340-D672, and V349-D672 and deletion mutants G5-R339 and M340-D672 all bound to S100A11 in a Ca 2ϩ -dependent manner. Quantification of the interaction of S100A11 with liposomebound annexin A6 in the presence of Ca 2ϩ indicated 1:1 stoichiometry. Since S100A11 is a stable dimer, this suggests the Ca 2ϩ -dependent complex consists of one S100A11 dimer and two annexin A6 molecules. This complex was confirmed by chemical cross-linking. S100A11, therefore, could crosslink two annexin A6 molecules and thereby connect two membranes through the phospholipid-binding surface on annexin A6. For example, such a mechanism could serve to bring the sarcoplasmic reticulum in close apposition to the plasma membrane. Since annexin A6 can also interact with cytoskeletal elements, the possibility arises that the S100A11-annexin A6 complex may connect the plasma membrane to the cytoskeleton. An agonist-induced increase in cytosolic free [Ca 2ϩ ] could lead to the formation of a heteromeric complex composed of two annexin A6 polypeptides cross-linked by an S100A11 dimer, to form a physical connection between the plasma membrane and the cytoskeleton that is essential for Fig. 10 . Smooth muscle cells express mRNA for both S100A11 and annexin A6. RT-PCR was performed on 3 separate preparations of mRNA from isolated vascular smooth muscle cells of the rat basilar artery using primers specific for S100A11 and annexin A6. Purity of the isolated cells was confirmed by the absence of message encoding endothelin-1 (an endothelial cell marker) and ERG-3 (a neuronal marker). M: DNA ladder. The identity of each PCR product was confirmed by sequencing. Full-length recombinant chicken annexin A6 and a partial tryptic digest of annexin A6 (see Fig. 8 ) were subjected to MALDI-TOF MS. Measured masses are compared with predicted masses from the sequence of chicken annexin A6. Residue numbers refer to the chicken annexin A6 amino acid sequence (see Fig. 2 ).
transmission of mechanical signals leading to contraction. Ca 2ϩ plays a dual role in this process since both S100A11 and annexin A6 are Ca 2ϩ -binding proteins. Ca 2ϩ ions play a key role in association of annexin A6 with the membrane and Ca 2ϩ binding to S100A11 inducing a conformational change with exposure of a hydrophobic surface that interacts with annexin A6.
The sarcolemma of smooth muscle cells is segregated into force-transmitting regions (adherens junctions), which are directly linked to the cytoskeleton, and flexible vesicular domains containing numerous caveolae and noncaveolar lipid raft domains (13, 35) . Together, the caveolae and stabilized noncaveolar rafts form an extensive lipid superstructure, a macroraft (sites of localization of signaling complexes). Since smooth muscle cells must adapt rapidly and continuously to changes in length, sarcolemmal and cytoskeletal protein reorganization must be precise and flexible. Members of the annexin protein family, including annexin A6, have been implicated in smooth muscle membrane organization, constituting a reversible, Ca 2ϩ -dependent link between the sarcolemma and the cytoskeleton (2) . Effective regulatory mechanisms for coordinated cytoskeletal and sarcolemmal rearrangement are required to protect smooth muscle cells from mechanical damage during contraction-relaxation cycles. Most interestingly, Draeger and coworkers provided evidence that annexin A6 translocates to the non-caveolar raft domains neighboring the caveolae to form a Ca 2ϩ -sensitive linker connecting this domain to the actin cytoskeleton (2) (3) (4) 14) . They proposed that this Ca 2ϩ -regulated connection protects the sarcolemma from mechanical damage during contraction and relaxation and enhances force transduction between the contractile machinery and the extracellular matrix. Since we have shown that S100A11 interacts with annexin A6 in a Ca 2ϩ -dependent manner, the possibility arises that this Ca 2ϩ -dependent linkage of the plasma membrane to the cytoskeleton also requires S100A11.
Evidence from other cell types has implicated annexin A6 in Ca 2ϩ -dependent formation of signaling complexes. For exam- Fig. 11 . Immunocytochemical analysis of annexin A6 and S100A11 in isolated rat caudal arterial smooth muscle cells. Top: isolated rat caudal arterial smooth muscle cells were fixed, permeabilized, and treated with anti-annexin A6 (left), anti-S100A11 (middle), or Hoechst 33342 nuclear stain (right). Middle: phase-contrast image of an isolated rat caudal arterial smooth muscle cell (left) treated with Hoechst nuclear stain (middle) and anti-annexin A6 preadsorbed with the peptide antigen to which the antibody was raised (right). Bottom left: Hoechst 33342 nuclear staining (left) of an isolated rat caudal arterial smooth muscle cell treated with anti-S100A11 preadsorbed with the antigen (full-length S100A11) to which the antibody was raised (right). Secondary antibodies were Alexa 488-conjugated goat anti-rabbit IgG and Cy3-conjugated goat anti-mouse IgG for detection of annexin A6 and S100A11, respectively. Bottom right: Hoechst 33342 nuclear staining (left) of an isolated rat caudal arterial smooth muscle cell treated with Alexa 488-conjugated goat anti-rabbit IgG (middle) or Cy3-conjugated goat anti-mouse IgG (right) in the absence of primary antibodies. All results are representative of Ն5 cells from each of 3 independent cell isolations. Values are means Ϯ SE; n ϭ 6. Ct, PCR cycle at which threshold is achieved (i.e., 2 Ϫ⌬C t ϭ 2 Ϫ(CtS100A11ϪCt␤-actin) ). mRNA was isolated from rat cerebral arterial smooth muscle and quantified by real-time PCR relative to ␤-actin, as described in MATERIALS AND METHODS.
ple, annexin A6 has been shown to associate in a Ca 2ϩ -dependent manner with lipid rafts along with PKC␣ and neurocalcin-␣ (27) and direct interaction between annexin A6 and skeletal muscle PKC␣ has been demonstrated (33) . Annexin A6 has also been identified in a complex with the GTPase activating protein p120 Ras-GAP and the tyrosine kinases Fyn and Pyk2, annexin A6 interacting directly with p120 Ras-GAP and Fyn, but not Pyk2 (7) . Future studies will focus on the association of S100A11 and annexin A6 with other proteins that will shed light on the physiological function of this Ca 2ϩ -dependent complex.
